FDA Warns of Celexa Heart Injuries
Find the Right Lawyer for Your Legal Issue!
Fast, Free, and Confidential
The FDA is warning the public about possible Celexa heart injuries for those patients taking larger doses of Forest Lab's popular anti-depressant drug. If you've been injured, find out how a Celexa heart injury attorney can help you get the compensation you deserve.
Celexa Heart Arrhythmia
The U.S. Food & Drug Administration (FDA) has issued a warning that the probability of suffering from a Celexa heart arrhythmia, Celexa heart palpitation or other Celexa heart injury increases as users increase the dosage of the drug. In fact, the FDA recommends lowering the daily dose of Celexa (citalopram hydrobromide) to no more than 40mg per day as anything higher may cause abnormal heart rhythms - particularly in those with "underlying heart conditions and those who tend to have low levels of potassium and magnesium in their blood."
The FDA warns physicians not to prescribe Celexa for patients with congenital long QT syndrome (LQTS) - a condition of the heart's electrical system which can lead to cardiac arrest or sudden death. It also urges Celexa users who experience shortness of breath, irregular heartbeat or dizziness while taking the drug to contact their doctor or healthcare provider.
However, the Administration tells patients that they should not stop taking the selective serotonin reuptake inhibitor (SSRI) used to treat depression or change their dose without first talking with their doctor as stopping suddenly can cause Celexa side effects.
Contact a Celexa Injury Lawyer for More Information
If you've been injured after Celexa, contact a Celexa injury lawyer to find out more information about whether or not you might be entitled to compensation, how long you have to file a Celexa injury lawsuit and how a Celexa injury attorney can help you through the process. Consultations are free of charge, strictly confidential and are meant to help you decide whether or not taking further action is in your best interests.